Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W5LS
|
||||
Former ID |
DAP001106
|
||||
Drug Name |
Desoxycorticosterone Pivalate
|
||||
Synonyms |
DOCP; DTMA; Percorten; Cortexone M; Deoxycorticosterone pivalate; Deoxycorticosterone trimethylacetate; Deoxycortolone Pivalate; Deoxycortone pivalate; Deoxycortone trimethylacetate; Desoxycorticosterone trimethylacetate; Desoxycortone pivalate; Percorten M; Percorten Pivalate; Desoxycorticosterone pivalate (USP); Neodin-depositum; Percorten (TN); Corticosterone, deoxy-, pivalate (6CI,7CI); [2-(10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 2,2-dimethylpropanoate; 11-Deoxycorticosterone pivalate; 11-Deoxycorticosterone, pivalate; 11-Deoxycorticosterone, pivalate (8CI); 21-(2,2-Dimethyl-1-oxopropoxy)pregn-4-ene-3,20-dione; 3,20-dioxopregn-4-en-21-yl 2,2-dimethylpropanoate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Addison's disease [ICD9: 255.4; ICD10:E27.1-E27.2] | Approved | [550742] | ||
Therapeutic Class |
Antiaddison Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H38O4
|
||||
Canonical SMILES |
CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C
|
||||
InChI |
1S/C26H38O4/c1-24(2,3)23(29)30-15-22(28)21-9-8-19-18-7-6-16-14-17(27)10-12-25(16,4)20(18)11-13-26(19,21)5/h14,18-21H,6-13,15H2,1-5H3/t18-,19-,20-,21+,25-,26-/m0/s1
|
||||
InChIKey |
VVOIQBFMTVCINR-WWMZEODYSA-N
|
||||
CAS Number |
CAS 808-48-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:50782
|
||||
SuperDrug ATC ID |
H02AA03
|
||||
Target and Pathway | |||||
Target(s) | Mineralocorticoid receptor | Target Info | Binder | [537791] | |
KEGG Pathway | Aldosterone-regulated sodium reabsorption | ||||
PathWhiz Pathway | Kidney Function | ||||
WikiPathways | ACE Inhibitor Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.